Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differences Between Clinical and Pathological Staging in Early Gastric Cancer (EGC): Evaluation of the Potential Impact of Applying Standard and Expanded Asian Endoscopic Resection Criteria in a Western Cohort and Analysis of Disease Progression and Long-Term Survival

NCT07781319 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT07781319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07781319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differences Between Clinical and Pathological Staging in Early Gastric Cancer (EGC): Evaluation of the Potential Impact of Applying Standard and Expanded Asian Endoscopic Resection Criteria in a Western Cohort and Analysis of Disease Progression and Long-Term Survival
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2022
Enrollment
600 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, gastric adenocarcinoma